ImmunoMolecular Therapeutics' Convertible Note Round

ImmunoMolecular Therapeutics raised a round of funding on August 03, 2016.

ImmunoMolecular Therapeutics is a private clinical stage biotech company developing a revolutionary therapeutic approach for the treatment of Type I Diabetes. The company was founded by world class r…

Articles about ImmunoMolecular Therapeutics' Convertible Note Round: